Literature DB >> 19438899

Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery.

A R Tzafriri1, A D Levin, E R Edelman.   

Abstract

BACKGROUND: Local drug delivery has transformed medicine, yet it remains unclear how drug efficacy depends on physicochemical properties and delivery kinetics. Most therapies seek to prolong release, yet recent studies demonstrate sustained clinical benefit following local bolus endovascular delivery.
OBJECTIVES: The purpose of the current study was to examine interplay between drug dose, diffusion and binding in determining tissue penetration and effect.
METHODS: We introduce a quantitative framework that balances dose, saturable binding and diffusion, and measured the specific binding parameters of drugs to target tissues.
RESULTS: Model reduction techniques augmented by numerical simulations revealed that impact of saturable binding on drug transport and retention is determined by the magnitude of a binding potential, B(p), ratio of binding capacity to product of equilibrium dissociation constant and accessible tissue volume fraction. At low B(p) (< 1), drugs are predominantly free and transport scales linearly with concentration. At high B(p) (> 40), drug transport exhibits threshold dependence on applied surface concentration.
CONCLUSIONS: In this paradigm, drugs and antibodies with large B(p) penetrate faster and deeper into tissues when presented at high concentrations. Threshold dependence of tissue transport on applied surface concentration of paclitaxel and rapamycin may explain threshold dose dependence of in vivo biological efficacy of these drugs.

Entities:  

Mesh:

Year:  2009        PMID: 19438899      PMCID: PMC2852623          DOI: 10.1111/j.1365-2184.2009.00602.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  39 in total

1.  Available space and extracellular transport of macromolecules: effects of pore size and connectedness.

Authors:  F Yuan; A Krol; S Tong
Journal:  Ann Biomed Eng       Date:  2001-12       Impact factor: 3.934

2.  Reaction diffusion model of the enzymatic erosion of insoluble fibrillar matrices.

Authors:  Abraham R Tzafriri; Michel Bercovier; Hanna Parnas
Journal:  Biophys J       Date:  2002-08       Impact factor: 4.033

Review 3.  The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.

Authors:  Kalpana R Kamath; James J Barry; Kathleen M Miller
Journal:  Adv Drug Deliv Rev       Date:  2006-03-06       Impact factor: 15.470

4.  Endosomal receptor kinetics determine the stability of intracellular growth factor signalling complexes.

Authors:  A Rami Tzafriri; Elazer R Edelman
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

5.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

Review 6.  Mechanisms of controlled drug release from drug-eluting stents.

Authors:  Ghanashyam Acharya; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2006-03-06       Impact factor: 15.470

7.  Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.

Authors:  Gunnar Tepe; Thomas Zeller; Thomas Albrecht; Stephan Heller; Uwe Schwarzwälder; Jean-Paul Beregi; Claus D Claussen; Anja Oldenburg; Bruno Scheller; Ulrich Speck
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

8.  Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution.

Authors:  Brinda Balakrishnan; John F Dooley; Gregory Kopia; Elazer R Edelman
Journal:  J Control Release       Date:  2007-07-05       Impact factor: 9.776

9.  Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.

Authors:  Arturo Garcia-Touchard; Sandra E Burke; John L Toner; Keith Cromack; Robert S Schwartz
Journal:  Eur Heart J       Date:  2006-01-31       Impact factor: 29.983

10.  The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).

Authors:  Patrick W Serruys; Georgios Sianos; Alexandre Abizaid; Jiro Aoki; Peter den Heijer; Hans Bonnier; Pieter Smits; Dougal McClean; Stefan Verheye; Jorge Belardi; Jose Condado; Michel Pieper; Louise Gambone; Marco Bressers; Janette Symons; Eduardo Sousa; Frank Litvack
Journal:  J Am Coll Cardiol       Date:  2005-07-19       Impact factor: 24.094

View more
  20 in total

1.  Stent elution rate determines drug deposition and receptor-mediated effects.

Authors:  Abraham R Tzafriri; Adam Groothuis; G Sylvester Price; Elazer R Edelman
Journal:  J Control Release       Date:  2012-05-26       Impact factor: 9.776

2.  Sustained Efficacy and Arterial Drug Retention by a Fast Drug Eluting Cross-Linked Fatty Acid Coronary Stent Coating.

Authors:  Natalie Artzi; Abraham R Tzafriri; Keith M Faucher; Geoffrey Moodie; Theresa Albergo; Suzanne Conroy; Scott Corbeil; Paul Martakos; Renu Virmani; Elazer R Edelman
Journal:  Ann Biomed Eng       Date:  2015-08-28       Impact factor: 3.934

3.  Binding and transport of PAMAM-RGD in a tumor spheroid model: the effect of RGD targeting ligand density.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Biotechnol Bioeng       Date:  2011-07-19       Impact factor: 4.530

Review 4.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Crit Rev Biomed Eng       Date:  2012

5.  Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug.

Authors:  Wenda C Carlyle; James B McClain; Abraham R Tzafriri; Lynn Bailey; Brett G Zani; Peter M Markham; James R L Stanley; Elazer R Edelman
Journal:  J Control Release       Date:  2012-07-16       Impact factor: 9.776

6.  Mathematical modelling of fluid flow and solute transport to define operating parameters for in vitro perfusion cell culture systems.

Authors:  Lauren Hyndman; Sean McKee; Nigel J Mottram; Bhumika Singh; Steven D Webb; Sean McGinty
Journal:  Interface Focus       Date:  2020-02-14       Impact factor: 3.906

7.  Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis.

Authors:  Abraham R Tzafriri; Fernando Garcia-Polite; Brett Zani; James Stanley; Benny Muraj; Jennifer Knutson; Robert Kohler; Peter Markham; Alexander Nikanorov; Elazer R Edelman
Journal:  J Control Release       Date:  2017-09-01       Impact factor: 9.776

8.  Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy.

Authors:  Vijaya B Kolachalama; Stephen D Pacetti; Joseph W Franses; John J Stankus; Hugh Q Zhao; Tarek Shazly; Alexander Nikanorov; Lewis B Schwartz; Abraham R Tzafriri; Elazer R Edelman
Journal:  Circulation       Date:  2013-04-12       Impact factor: 29.690

9.  Lesion complexity determines arterial drug distribution after local drug delivery.

Authors:  Abraham R Tzafriri; Neda Vukmirovic; Vijaya B Kolachalama; Irina Astafieva; Elazer R Edelman
Journal:  J Control Release       Date:  2009-11-17       Impact factor: 9.776

10.  High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery.

Authors:  Mikhail Y Maslov; Elazer R Edelman; Abraham E Wei; Matthew J Pezone; Mark A Lovich
Journal:  J Control Release       Date:  2013-07-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.